Enhancement of in vivo endothelialization of tissue‐engineered vascular grafts by granulocyte colony‐stimulating factor
- 1 November 2005
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 76A (2) , 252-263
Abstract
Successful reconstruction of large‐diameter blood vessel in humans has been demonstrated using the tissue engineering technique, but improvement in patency of small‐diameter bioartificial vascular graft remains a great challenge. This study reports that granulocyte colony‐stimulating factor (G‐CSF) can enhance in vivo endothelialization of tissue‐engineered vascular grafts, which could be used to improve patency of small‐diameter vascular graft. Vascular grafts were tissue engineered with decellularized canine abdominal aortas and canine autologous bone marrow–derived cells. Prior to cell seeding onto decellularized graft matrices, bone marrow–derived cells were induced to differentiate into endothelial cells and smooth muscle cells. The cell‐seeded vascular grafts were implanted into the abdominal aortas of bone marrow donor dogs. Before and after graft implantation, G‐CSF was administered subcutaneously to the dogs (n = 3). The grafts implanted into the dogs not receiving G‐CSF were used as controls (n = 3). Eight weeks after implantation, grafts in both groups showed regeneration of vascular tissues including endothelium and smooth muscle. Importantly, endothelium formation was more extensive in the G‐CSF–treated grafts than in the control grafts, as assessed with reverse transcription polymerase chain reaction, western blot, and immunohistochemistry. In addition, intimal hyperplasia was significantly reduced in the G‐CSF–treated grafts compared to the control grafts. This study suggests that G‐CSF administration could be applied to improve patency of small‐diameter tissue‐engineered vascular grafts. © 2005 Wiley Periodicals, Inc. J Biomed Mater Res, 2006Keywords
This publication has 31 references indexed in Scilit:
- Vascular patches tissue-engineered with autologous bone marrow-derived cells and decellularized tissue matricesBiomaterials, 2005
- Cytokine-Induced Mobilization of Circulating Endothelial Progenitor Cells Enhances Repair of Injured ArteriesCirculation, 2004
- Decellularized vein as a potential scaffold for vascular tissue engineeringJournal of Vascular Surgery, 2004
- Cytokine therapy prevents left ventricular remodeling and dysfunction after myocardial infarction through neovascularizationThe FASEB Journal, 2004
- Explant pathology study of decellularized carotid artery vascular graftsJournal of Biomedical Materials Research Part A, 2004
- First Evidence That Bone Marrow Cells Contribute to the Construction of Tissue-Engineered Vascular Autografts In VivoCirculation, 2003
- Endothelial functionThe American Journal of Cardiology, 2002
- Vascular Endothelial Growth Factor (VEGF) Enhances the Expression of Receptors and Activates Mitogen-Activated Protein (MAP) Kinase of Dog Retinal Capillary Endothelial CellsJournal of Ocular Pharmacology and Therapeutics, 2000
- eNOS-Overexpressing Endothelial Cells Inhibit Platelet Aggregation and Smooth Muscle Cell Proliferation in VitroTissue Engineering, 2000
- Dynamic changes of smooth muscle and endothelial markers in the early healing process of dacron vascular grafts in the dog, using RT-PCRInternational Journal of Angiology, 2000